Publications by authors named "Naoki Isogawa"

Claim this Profile
P
Performance Evaluation of Interim Analysis in Bioequivalence Studies.
Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo

Ther Innov Regul Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki Isogawa.
Naoki Isogawa, Andy Grieve, Ryota Ishii, Kazushi Maruo

Ther Innov Regul Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.
Mikihiro Fujiya, Tsutomu Kawaguchi, Shoko Arai, Naoki Isogawa, Shintaro Hiro

Dig Dis Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies.
Kenji Miki, Makoto Ohta, Manabu Abe, Hiroki Yoshimatsu, Koichi Fujii, Naoki Isogawa

Pain Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.
Shin-Ichi Konno, Takuya Nikaido, John D Markman, Makoto Ohta, Toshiya Machida, Naoki Isogawa

Pain Manag· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
Francis Berenbaum, Richard Langford, Serge Perrot, Kenji Miki, Francisco J Blanco, Naoki Isogawa

Eur J Pain· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Borrowing external information to improve Bayesian confidence propagation neural network.
Keisuke Tada, Kazushi Maruo, Naoki Isogawa, Yusuke Yamaguchi, Masahiko Gosho

Eur J Clin Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.
Naoki Isogawa, Kentaro Takeda, Kazushi Maruo, Takashi Daimon

Ther Innov Regul Sci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA study.
Masayuki Saruta, Dong Il Park, Young-Ho Kim, Suk-Kyun Yang, Byung-Ik Jang, Naoki Isogawa

Intest Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis.
Yasuo Suzuki, Mamoru Watanabe, Toshiyuki Matsui, Satoshi Motoya, Tadakazu Hisamatsu, Naoki Isogawa

Inflamm Intest Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.
Naoki Isogawa, Kentaro Takeda, Kazushi Maruo, Takashi Daimon

Ther Innov Regul Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.
Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Naoki Isogawa

Intest Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.
Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Naoki Isogawa

Intest Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.
Masatoshi Abe, Chikako Nishigori, Hideshi Torii, Hironobu Ihn, Kei Ito, Naoki Isogawa

J Dermatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Japan phase 3 study of pegaptanib sodium in patients with diabetic macular edema].
Tatsuro Ishibashi, Mitsuko Yuzawa, Nagahisa Yoshimura, Masahito Ohji, Susumu Ishida, Naoki Isogawa

Nippon Ganka Gakkai Zasshi· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis